Clinical Trial Update: INSPIRE Diabetes Study: Basal Bolus Insulin as Primary Treatment of Type 2 Diabetes [Phase 4]

View source ↗

Summary

The INSPIRE Diabetes Study, a Phase 4 trial evaluating basal-bolus insulin as the primary treatment for Type 2 Diabetes, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Basal-Bolus Insulin regimen

Snippet

Sponsor: Ohio University | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED